Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC) (EPIC)
Sponsor: Duke University
Terminated
Sponsor did not renew funding.
This observational or N/A phase trial investigates Cannabis Use and Development, Infant and is currently terminated or withdrawn. Duke University leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Apr 2023 — Jul 2024 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Jun 2022 — Apr 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Oct 2021 — Jun 2022 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Jun 2021 — Oct 2021 [monthly]
Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2020 — Dec 2020 [monthly]
Not Yet Recruiting
-
Jul 2020 — Oct 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- John Templeton Foundation
For direct contact, visit the study record on ClinicalTrials.gov .